Toxic shock syndrome other diagnostic studies: Difference between revisions
No edit summary |
|||
| Line 2: | Line 2: | ||
{{CMG}},{{AE}}{{MIR}} | {{CMG}},{{AE}}{{MIR}} | ||
== | == Overview: == | ||
Although the best [[Diagnosis|diagnostic]] tool for [[toxic shock syndrome]] (TSS) [[diagnosis]] is with clinical findings and laboratory exams, there are still some | Although the best [[Diagnosis|diagnostic]] tool for [[toxic shock syndrome]] (TSS) [[diagnosis]] is with clinical findings and laboratory exams, there are still some specific diagnostic ways to confirm TSS diagnosis. | ||
__NOTOC__ | __NOTOC__ | ||
Revision as of 02:40, 16 May 2017
|
Toxic shock syndrome Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Toxic shock syndrome other diagnostic studies On the Web |
|
American Roentgen Ray Society Images of Toxic shock syndrome other diagnostic studies |
|
Risk calculators and risk factors for Toxic shock syndrome other diagnostic studies |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1],Associate Editor(s)-in-Chief: Mahshid Mir, M.D. [2]
Overview:
Although the best diagnostic tool for toxic shock syndrome (TSS) diagnosis is with clinical findings and laboratory exams, there are still some specific diagnostic ways to confirm TSS diagnosis.
Frozen-section biopsy
Early recognition of necrotizing fasciitis (NF) can be made by using of specimens of suspected areas of tissue ; however, it requires high expertise to process and interpret biopsy specimens, which is not readily available in most clinical settings where and when patients present[1].
Staphylococcus aureus antibody testing
Presence of Staphylococcus aureus in the absence of an acute-phase antibody can be highly suggestive of Staphylococcal TSS.
References
- ↑ Stamenkovic I, Lew PD (1984). "Early recognition of potentially fatal necrotizing fasciitis. The use of frozen-section biopsy". N. Engl. J. Med. 310 (26): 1689–93. doi:10.1056/NEJM198406283102601. PMID 6727947.